AIM: to observe the distribution and expression of two subtypes of very low density lipoprotein receptor (VLDL r) in diabetic adipose tissues to investigate their changes and significance.
目的：观察极低密度脂蛋白受体(VLDL -R)的两种亚型在糖尿病患者脂肪组织中的分布和表达，以探讨其变化及意义。
There are many types of receptors secreted the oxidized low density lipoprotein, especially scavenger receptor a.
介导氧化修饰低密度脂蛋白的受体种类繁多，尤其是清道夫受体a。
Objective to investigate the effects of oxidized low-density lipoprotein receptor 1 (LOX-1) on secretion of adhesive molecules mediated by ox-LDL in human umbilical endothelial cells (HUVECs).
目的探讨血凝素样氧化低密度脂蛋白受体1 (LOX - 1)在氧化低密度脂蛋白(ox - LDL)诱导血管内皮细胞粘附分子表达中的作用。
Early glycated low density lipoprotein (LDL) was not recognized by this receptor. AGEP BSA elevated cytosolic free calcium in a concentration dependent manner.
通过该受体介导，平滑肌细胞可内化、代谢AGEP．AGEP使胞浆游离钙呈浓度依赖性升高；
For instance, familial hypercholesterolemia (FH) typically results from mutations in LDLR encoding the low-density lipoprotein (LDL) receptor.
例如，家族性血胆脂醇过多症(FH)通常起源于编码低密度脂蛋白(LDL)受体的LDLR突变。
The human skeleton is affected by mutations in low-density lipoprotein receptor-related protein 5 (LRP5).
低密度脂蛋白受体相关蛋白5 (LRP5)基因突变可影响人体骨骼。
The human skeleton is affected by mutations in low-density lipoprotein receptor-related protein 5 (LRP5).
低密度脂蛋白受体相关蛋白5 (LRP5)基因突变可影响人体骨骼。
应用推荐